Bioengineering to treat diabetes in the media
Search Results for:
PhD Thesis Defence: Francina Mesquida Veny
Activity-dependent mechanisms of axonal growth Francina Mesquida Veny, Molecular and cellular neurobiotechnology This thesis defence will take place at “Aula de Graus” Facultat de Biologia, Universitat de Barcelona” at 11AM. … Read more
PhD Thesis Defence: Francina Mesquida Veny
Activity-dependent mechanisms of axonal growth Francina Mesquida Veny, Molecular and cellular neurobiotechnology This thesis defence will take place at “Aula de Graus” Facultat de Biologia, Universitat de Barcelona” at 11AM. … Read more
PhD Thesis Defence: Francina Mesquida Veny
Activity-dependent mechanisms of axonal growth Francina Mesquida Veny, Molecular and cellular neurobiotechnology This thesis defence will take place at “Aula de Graus” Facultat de Biologia, Universitat de Barcelona” at 11AM. … Read more
BRIGHTER on the radio
Elena Martínez, main researcher at IBEC, appears on radio 5, from RTVE, for her research on the creation of artificial skin that could be used to replace some animal experimentation methods.
IBECer James Eills wins the Erwin Schrödinger Prize
BIST-FBA Fellow at IBEC, Dr. James Eills, is part of an international team that has received the Erwin Schrödinger Prize. Eills, current Postdoc at the Group of Irene Marco at IBEC, contributed in Germany to a technique that amplifies magnetic resonance signals.
Josep Samitier, technology and health on “Ràdio Estel”
Josep Samitier, director of the Institute for Bioengineering of Catalonia, is interviewed on the program “Tot anirà bé” of “Ràdio Estel” for the technological and health advances that are being carried out at IBEC.
Progress towards the regeneration of the human retina
The media have published the new discovery made by scientists from the Center for Genomic Regulation (CRG) and financed mainly by a CaixaResearch Health Research Project of the Fundació “la Caixa” awarded to Pia Cosma (CRG), Nuria Montserrat (IBEC) and Justin Christopher D’Antin (Barraquer).
Innovative bioengineered spheres might help treating diabetes
Researchers from IBEC, in collaboration with IDIBAPS in Barcelona, have developed nontoxic small spheres able to respond to variations in glucose levels, and producing insulin in vitro. These biomimetic spheroids containing pancreatic β-cells were prepared based on 3D bioprinting. This approach might help in the future improving clinical outcomes of β-cell transplantation strategies for diabetes treatment, as well as for in vitro drug screening platforms.
IBEC Seminar: Alejandro Mayorca
Mapping the structure of the extracellular matrix and engineering matrixbased disease models Alejandro Mayorca, Biotech Research and Innovation Centre, University of Copenhagen Understanding disease necessitates a precise representation of the … Read more